Ardelli BF, Prichard RK (2013) Inhibition of P-glycoprotein enhances sensitivity of Caenorhabditis elegans to ivermectin. Vet Par 191:264–275. https://doi.org/10.1016/j.vetpar.2012.09.021

Article  CAS  Google Scholar 

Benedetto A, Au C, Avila DS, Milatovic D, Aschner M (2010) Extracellular dopamine potentiates Mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans. PLoS Genet 6:e1001084. https://doi.org/10.1371/journal.pgen.1001084

Article  CAS  PubMed  PubMed Central  Google Scholar 

Betti AH, Stein AC, Dallegrave E, Wouters AT, Watanabe TT, Driemeier D, Buffon A, Rates SM (2012) Acute and repeated-doses (28 days) toxicity study of Hypericum polyanthemum Klotzsch ex Reichardt (Guttiferare) in mice. Food Chem Toxicol 50:2349–2355. https://doi.org/10.1016/j.fct.2012.04.012

Article  CAS  PubMed  Google Scholar 

Betti AH, Stolz ED, Barros FMC, Müller LG, Von Poser GL, Rego JL, Rego JC, Vaudry D, Rates SMK (2016) Dimeric phloroglucinol derivatives but not benzopyrans from Hypericum species have no toxicity on cerebellar primary neurons. Int J Pharmacogn Phytochem Res 8:446–452

Google Scholar 

Borsoi M, Batassini C, Lazzaretti C, Silvestrin RB, Betti AH, Stein AC, von Poser GL, Rates SMK, Souza TME (2018) Hypericum polyanthemum cyclohexane extract potentiates behavioral effects and neurodegeneration induced by nigral infusions of 6-hydroxydopamine in rats. Neurosci Lett 687:177–182. https://doi.org/10.1016/j.neulet.2018.09.048

Article  CAS  PubMed  Google Scholar 

Bridi H, Meirelles GC, von Poser GL (2018) Structural diversity and biological activities of phloroglucinol derivatives from Hypericum species Phytochemistry 155:203–232. https://doi.org/10.1016/j.phytochem.2018.08.002

Article  CAS  PubMed  Google Scholar 

Broeks A, Plasterk RHA (1994) The C. elegans pgp-3 gene is involved in resistance to the drugs chloroquine and colchicine. Worm Breeder’s Gazette 13:69

Google Scholar 

Broeks A, Janssen HW, Calafat J, Plasterk RH (1995) A P-glycoprotein protects Caenorhabditis elegans against natural toxins. EMBO J 14:1858–1866. https://doi.org/10.1002/j.1460-2075.1995.tb07178.x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cargnin ST, Vieira PB, Cibulski S, Cassel E, Vargas RM, Montanha J, Roehe P, Tasca T, von Poser GL (2013) Anti-Trichomonas vaginalis activity of Hypericum polyanthemum extract obtained by supercritical fluid extraction and isolated compounds. Parasitol Int 62:112–117. https://doi.org/10.1016/j.parint.2012.10.006

Article  CAS  PubMed  Google Scholar 

Cheon SM, Jang I, Lee MH, Kim DK, Jeon H, Cha DS (2017) Sorbus alnifolia protects dopaminergic neurodegeneration in Caenorhabditis elegans. Pharm Biol 55:481–486. https://doi.org/10.1080/13880209.2016.1251468

Article  PubMed  Google Scholar 

Engleman EA, Katner SN, Neal-Beliveau SB (2016) Caenorhabditis elegans as a model to study the molecular and genetic mechanisms of drug addiction. Prog Mol Biol Transl Sci 137:229–252. https://doi.org/10.1016/bs.pmbts.2015.10.019

Article  PubMed  Google Scholar 

Espiñeira MG, Benitez LT, Verbel JO (2018) Toxicity of atrazine- and glyphosate-based formulations on Caenorhabditis elegans. Ecotox Environ Safe 156:216–222. https://doi.org/10.1016/j.ecoenv.2018.02.075

Article  CAS  Google Scholar 

Hunt PR (2017) The C. elegans model in toxicity testing. J Appl Toxicol 37:50–59. https://doi.org/10.1002/jat.3357

Article  CAS  PubMed  Google Scholar 

Kudumala S, Sossi S, Carvelli L (2019) Swimming induced paralysis to assess dopamine signaling in Caenorhabditis elegans. J vis Exp 146:e59243. https://doi.org/10.3791/59243

Article  CAS  Google Scholar 

Lincke CR, The I, van Groenigen M, Borst P (1992) The P-glycoprotein gene family of Caenorhabditis elegans. Cloning and characterization of genomic and complementary DNA sequences. J Mol Biol 228:701–711. https://doi.org/10.1016/0022-2836(92)90855-e

Article  CAS  PubMed  Google Scholar 

Machado CP, da Neves GM, von Poser GL, Eifler-Lima V, Rates SMK (2023) In silico prediction of ADMET/drug-likeness properties of bioactive phloroglucinols from Hypericum genus. Med Chem 19:1002–1017. https://doi.org/10.2174/1573406419666230601092358

Article  CAS  Google Scholar 

Marangon CG, Rojas CS, Michelsen MZ, Sakamoto S, Jacques CED, von Poser GL, Vargas CR, Rates SMK (2023) Uliginosin B, a natural phloroglucinol, increases hippocampal GSH, MCP-1 and IL-10 levels in mice. Rev Bras Farmacogn 33:1274–1286. https://doi.org/10.1007/s43450-023-00459-7

Article  CAS  Google Scholar 

Nass R, Blakely RD (2003) The Caenorhabditis elegans dopaminergic system: opportunities for insights into dopamine transport and neurodegeneration. Annu Rev Pharmacol Toxicol 43:521–544. https://doi.org/10.1146/annurev.pharmtox.43.100901.135934

Article  CAS  PubMed  Google Scholar 

Ng QX, Venkatanarayanan N, Ho CY (2017) Clinical use of Hypericum perforatum (St John’s wort) in depression: a meta-analysis. J Affect Disord 210:211–221. https://doi.org/10.1016/j.jad.2016.12.048

Article  CAS  PubMed  Google Scholar 

Nicolussi S, Drewe J, Butterweck V, Meyer HEMZ Schwabedissen (2020) Clinical relevance of St. John's wort drug interactions revisited. Br J Pharmacol 177:1212–1226. https://doi.org/10.1111/bph.14936

Nör C, Albring D, Ferraz A, Schripsema J, Pires V, Sonnet P, Guillaume D, von Poser GL (2004) Phloroglucinol derivatives from four Hypericum species belonging to the Trigynobrathys section. Biochem Syst Ecol 32:517–519. https://doi.org/10.1016/j.bse.2003.10.011

Article  CAS  Google Scholar 

Robinson SB, Refai O, Hardaway JA, Sturgeon S, Popay T, Bermingham DP, Freeman P, Wright J, Blakely RD (2019) Dopamine-dependent, swimming-induced paralysis arises as a consequence of loss of function mutations in the RUNX transcription factor RNT-1. PLoS ONE 14:e0216417. https://doi.org/10.1371/journal.pone.0216417

Article  PubMed  PubMed Central  Google Scholar 

Shrader SH, Tong YG, Duff MB, Freedman JH, Song ZH (2020) Involvement of dopamine receptor in the actions of non-psychoactive phytocannabinoids. Biochem Biophys Res Commun 533:1366–1370. https://doi.org/10.1016/j.bbrc.2020.10.021

Article  CAS  PubMed  PubMed Central  Google Scholar 

Srinivas N, Maffuid K, Kashuba ADM (2018) Clinical pharmacokinetics and pharmacodynamics of drugs in the central nervous system. Clin Pharmacokinet 57:1059–1074. https://doi.org/10.1007/s40262-018-0632-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stein AC, Viana AF, Müller LG, Nunes JM, Stolz ED, Do Rego JC, Costentin J, von Poser GL, Rates SMK (2012) Uliginosin B, a phloroglucinol derivative from Hypericum polyanthemum: a promising new molecular pattern for the development of antidepressant drugs. Behav Brain Res 228:66–73. https://doi.org/10.1016/j.bbr.2011.11.031

Article  CAS  PubMed  Google Scholar 

Stein AC, Müller LG, Ferreira AGK, Braga A, Betti A, Centurião FB, Scherer EB, Kolling J, von Poser GL, Wyse ATS, Rates SMK (2016) Uliginosin B, a natural phloroglucinol derivative with antidepressant-like activity, increases Na+, K+-ATPase activity in mice cerebral cortex. Rev Bras Farmacogn 26:611–618. https://doi.org/10.1016/j.bjp.2016.04.005

Article  CAS  Google Scholar 

Stolz ED, Viana AF, Hasse DR, von Poser GL, do Rego JC, Rates SMK (2012) Uliginosin B presents antinociceptive effect mediated by dopaminergic and opioid systems in mice. Prog Neuro-Psychoph 39:80–87. https://doi.org/10.1016/j.pnpbp.2012.05.012

Article  CAS  Google Scholar 

Stolz ED, Hasse DR, von Poser GL, Rates SMK (2014) Uliginosin B, a natural phloroglucinol derivative, presents a multimediated antinociceptive effect in mice. J Pharm Pharmacol 66:1774–1785. https://doi.org/10.1111/jphp.12307

Article  CAS  PubMed  Google Scholar 

Stolz ED, Costa PF, Medeiros LF, Souza A, Battastini AMO, von Poser GL, Bonan C, Torres ILS, Rates SMK (2016) Uliginosin B, a possible new analgesic drug, acts by modulating the adenosinergic system. Evid-Based Compl Alt Med 2014:5890590. https://doi.org/10.1155/2016/5890590

Article  Google Scholar 

Stolz ED (2014) Study of the antinociceptive mechanism of action of uliginosin B. Doctoral Thesis, Pharmaceutical Science Graduate Program, Federal University of Rio Grande do Sul, Brazil. 132 p. https://lume.ufrgs.br/handle/10183/148099

Wang E, Barechi-Roach M, Jonhson WW (2004) Quantitative characterization of direct P-glycoprotein inhibition by St. John wort constituents’ hypericin and hyperforin. J Pharm Pharmacol 56:123–128. https://doi.org/10.1211/0022357022395

Article